MedAlliance Announces First Patient Enrolled in the 3,300 Pati...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GENEVA, Sept. 1, 2021, /PRNewswire-AsiaNet/ -- MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR(TM), a novel sirolimus drug-eluting balloon [DEB], versus a limu...
Authors: LATEST ASIANET NEWS RELEASES